• 1
    Collaborative Group on Drug Use in Pregnancy (C.G.D.U.P). Medication during pregnancy: an international cooperative study. Int J Gynaecol Obstet. 1992; 9: 185196.
  • 2
    Khera KS. Maternal toxicity of drugs and metabolic disorders — a possible etiologic factor in the intrauterine death and congenital malformation: a critique on human data. Crit Rev Toxicol. 1987; 7: 345375.
  • 3
    Myrianthopoulos NC, Melnick M. Studies in neural tube defects. I. Epidemiologic and etiologic aspects. Am J Med Genet. 1987; 6: 783796.
  • 4
    Broekhuizen FF, Utrie J, Van Mullem C. Drug use or inadequate prenatal care? Adverse pregnancy outcome in an urban setting. Am J Obstet Gynecol. 1992; 66: 17471754.
  • 5
    Bennett AD. Perinatal substance abuse and the drug-exposed neonate. Adv Nurse Pract. 1999; 7: 3236.
  • 6
    D'Apolito K. Substance abuse: infant and childhood outcomes. J Pediatr Nurs. 1998; 13: 307316.
  • 7
    Czeizel AE, Szegal BA, Joffe JM, Racz J. The effect of diazepam and promethazine treatment during pregnancy on the somatic development of human offspring. Neurotoxicol Teratol. 1999; 21: 157167.
  • 8
    Richardson GA, Conroy ML, Day NL. Prenatal cocaine exposure: effects on the development of school-age children. Neurotoxicol Teratol. 1996; 18: 627634.
  • 9
    Linet MS, Devesa SS. Descriptive epidemiology of childhood leukaemia. Br J Cancer. 1991; 63: 424429.
  • 10
    Sandler DP, Ross JA. Epidemiology of acute leukemia in children and adults. Semin Oncol. 1997; 24: 316.
  • 11
    Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA. 1997; 94: 1395013954.
  • 12
    Ford AM, Pombo-de-Oliveira MS, McCarthy KP, et al. Monoclonal origin of concordant T-cell malignancy in identical twins. Blood. 1997; 89: 281285.
  • 13
    Robison LL, Buckley JD, Daigle AE, et al. Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring — an epidemiologic investigation implicating marijuana (a report from the Childrens Cancer Study Group). Cancer. 1989; 63: 19041911.
  • 14
    Bernstein L, Ross RK. Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: preliminary results from a case-control study in Los Angeles County. Cancer Res. 1992; 52 (suppl): 5510s5515s.
  • 15
    Doody MM, Linet MS, Glass AG, et al. Risks of non-Hodgkin's lymphoma, multiple myeloma, and leukemia associated with common medications. Epidemiology. 1996; 7: 131139.
  • 16
    Friedman GD. Phenylbutazone, musculoskeletal disease, and leukemia. J ChronicDis. 1982; 35: 233243.
  • 17
    Shu XO, Gao YT, Linet MS, et al. Chloramphenicol use and childhood leukaemia in Shanghai. Lancet. 1987; 2: 934937.
  • 18
    Yuan JM, Castelao JE, Gago-Dominguez M, Ross RK, Yu MC. Hypertension, obesity and their medications in relation to renal cell carcinoma. Br J Cancer. 1998; 77: 15081513.
  • 19
    Robison LL, Buckley JD, Bunin G. Assessment of environmental and genetic factors in the etiology of childhood cancers: the Childrens Cancer Group Epidemiology Program. Environ Health Perspect. 1995; 103 (suppl 6): 111116.
  • 20
    Robison LL, Daigle A. Control selection using random digit dialing for cases of childhood cancer. Am J Epidemiol. 1984; 120: 164166.
  • 21
    Shu XO, Linet MS, Steinbuch M, et al. Breast-feeding and risk of childhood acute leukemia. J Natl Cancer Inst. 1999; 91: 17651772.
  • 22
    Buitendijk S, Bracken MB. Medication in early pregnancy: prevalence of use and relationship to maternal characteristics. Am J Obstet Gynecol. 1991; 165: 3340.
  • 23
    Menard MK. Vitamin and mineral supplement prior to and during pregnancy. Obstet Gynecol Clin North Am. 1997; 24: 479498.
  • 24
    Czeizel AE, Rockenbauer M. Prevention of congenital abnormalities by vitamin A. Int J Vitam Nutr Res. 1998; 68: 219231.
  • 25
    Yong LC, Brown CC, Schatzkin A, et al. Intake of vitamins E, C, and A and risk of lung cancer. The NHANES I epidemiologic followup study. First National Health and Nutrition Examination Survey. Am J Epidemiol. 1997; 146: 231243.
  • 26
    John EM, Schwartz GG, Dreon DM, Koo J. Vitamin D and breast cancer risk: the NHANES I epidemiologic follow-up study, 1971–1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev. 1999; 8: 399406.
  • 27
    Rao M, Liu FS, Dawsey SM, et al. Effects of vitamin/mineral supplementation on the proliferation of esophageal squamous epithelium in Linxian, China. Cancer Epidemiol Biomarkers Prev. 1994; 3: 277279.
  • 28
    You WC, Blot WJ, Chang YS, et al. Diet and high risk of stomach cancer in Shangdong, China. Cancer Res. 1988; 48: 35183523.
  • 29
    Bostick RM, Potter JD, McKenzie DR, et al. Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women's Health Study. Cancer Res. 1993; 53: 42304237.
  • 30
    Ziegler RG. A review of epidemiologic evidence that carotenoids reduce the risk of cancer. J Nutr. 1989; 119: 116122.
  • 31
    van Poppel G, van den Berg H. Vitamins and cancer. Cancer Lett. 1997; 114: 195202.
  • 32
    Preston-Martin S, Pogoda JM, Mueller BA, et al. Results from an international case-control study of childhood brain tumors: the role of prenatal vitamin supplementation. Environ Health Perspect. 1998; 106 (suppl): 887892.
  • 33
    Thompson JR, Gerald PF, Willoughby MLN, Armstron BK. Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukemia in childhood: a case-control study. Lancet. 2001; 358: 19351940.
  • 34
    Roman E, Ansell P, Bull D. Leukaemia and non-Hodgkin's lymphoma in children and young adults: are prenatal and neonatal factors important determinants of disease? Br J Cancer. 1997; 76: 406415.
  • 35
    Petridou E, Trichopoulos D, Kalapothaki V, et al. The risk profile of childhood leukaemia in Greece: a nationwide case-control study. Br J Cancer. 1997; 76: 12411247.
  • 36
    Nahas G, Latour C. The human toxicity of marijuana. Med J Aust. 1992; 156: 495497.
  • 37
    Lindblad P, Wolk A, Bergstrom R, Persson I, Adami HO. The role of obesity and weight fluctuations in the etiology of renal cell cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 1994; 3: 631639.
  • 38
    Cordier S, Iglesias MJ, Le Goaster C, Guyot MM, Mandereau L, Hemon D. Incidence and risk factors for childhood brain tumors in the Ile de France. Int J Cancer. 1994; 59: 776782.
  • 39
    Chen CS, Sorensen PH, Domer PH, et al. Molecular rearrangements on chromosome 11q23 predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood. 1993; 81: 23862393.
  • 40
    Ross JA, Potter JD, Reaman GH, Pendergrass TW, Robison LL. Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group. Cancer Causes Control. 1996; 7: 581590.
  • 41
    Rockenbauer M, Olsen J, Czeizel AE, Pedersen L, Sorensen HT, the EuroMAP Group. Recall bias in a case-control surveillance system on the use of medicine during pregnancy. Epidemiology. 2001; 12: 461466.
  • 42
    Patterson RE, White E, Kristal AR, Neuhouser ML, Potter JD. Vitamin supplements and cancer risk: the epidemiologic evidence. Cancer Causes Control. 1997; 8: 786802.